Anti-inflammatory drugs, eicosanoids and the annexin A1/FPR2 anti-inflammatory system

Prostaglandins and Other Lipid Mediators

Volumn 98, Issue 3-4, 2012, Pages 94-100

  Yazid, Samia ^a   Norling, Lucy V ^a   Flower, Rod J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cromones; Cyclo oxygenase; Formyl peptide receptors; Glucocorticoids; Lipoxins; NSAIDs

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; ACETYLSALICYLIC ACID; CELECOXIB; CROMOGLYCATE DISODIUM; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FORMYLPEPTIDE RECEPTOR; GLUCOCORTICOID; GOLD; ICOSANOID; LIPOCORTIN 1; LIPOXIN; NAPROXEN; NEDOCROMIL; PENICILLAMINE; ROFECOXIB;

ASTHMA; CELL SURFACE; CELLULAR DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; HOST RESISTANCE; HUMAN; INFLAMMATION; NONHUMAN; PROTEIN SYNTHESIS; REVIEW; TARGET CELL; TISSUE DISTRIBUTION;

ANIMALS; ANNEXIN A1; ANTI-INFLAMMATORY AGENTS; EICOSANOIDS; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; RECEPTORS, FORMYL PEPTIDE;

EID: 84864489595     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.11.005     Document Type: Review

References (98)

1. S.H. Ferreira, S. Moncada, and J.R. Vane Indomethacin and aspirin abolish prostaglandin release from the spleen Nat New Biol 231 1971 237 239
2. J.B. Smith, and A.L. Willis Aspirin selectively inhibits prostaglandin production in human platelets Nat New Biol 231 1971 235 237
3. J.R. Vane Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs Nat New Biol 231 1971 232 235
4. J.G. Collier, and R.J. Flower Effect of aspirin on human seminal prostaglandins Lancet 2 1971 852 853
5. R.J. Flower Drugs which inhibit prostaglandin biosynthesis Pharmacol Rev 26 1974 33 67
6. R. Flower, R. Gryglewski, K. Herbaczynska-Cedro, and J.R. Vane Effects of anti-inflammatory drugs on prostaglandin biosynthesis Nat New Biol 238 1972 104 106
7. J.P. Merlie, D. Fagan, J. Mudd, and P. Needleman Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase) J Biol Chem 263 1988 3550 3553
8. D.L. DeWitt, E.A. el-Harith, and W.L. Smith Molecular cloning of prostaglandin G/H synthase Adv Prostaglandin Thromboxane Leukot Res 19 1989 454 457
9. W.L. Xie, J.G. Chipman, D.L. Robertson, R.L. Erikson, and D.L. Simmons Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing Proc Natl Acad Sci U S A 88 1991 2692 2696
10. D.A. Kujubu, B.S. Fletcher, B.C. Varnum, R.W. Lim, and H.R. Herschman TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue J Biol Chem 266 1991 12866 12872
11. G.P. O'Neill, and A.W. Ford-Hutchinson Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues FEBS Lett 330 1993 156 160
12. G.E. Evett, W. Xie, J.G. Chipman, D.L. Robertson, and D.L. Simmons Prostaglandin G/H synthase isoenzyme 2 expression in fibroblasts: regulation by dexamethasone, mitogens, and oncogenes Arch Biochem Biophys 306 1993 169 177
13. S. Kargman, S. Charleson, and M. Cartwright Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts Gastroenterology 111 1996 445 454
14. D. Picot, P.J. Loll, and R.M. Garavito The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1 Nature 367 1994 243 249
15. R.G. Kurumbail, A.M. Stevens, and J.K. Gierse Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents Nature 384 1996 644 648
16. 2-terminal serine of prostaglandin synthetase by aspirin J Biol Chem 253 1978 3782 3784
17. G.J. Roth, N. Stanford, and P.W. Majerus Acetylation of prostaglandin synthase by aspirin Proc Natl Acad Sci U S A 72 1975 3073 3076
18. J.K. Gierse, J.J. McDonald, S.D. Hauser, S.H. Rangwala, C.M. Koboldt, and K. Seibert A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors J Biol Chem 271 1996 15810 15814
19. O.Y. So, L.E. Scarafia, A.Y. Mak, O.H. Callan, and D.C. Swinney The dynamics of prostaglandin H synthases. Studies with prostaglandin h synthase 2 Y355F unmask mechanisms of time-dependent inhibition and allosteric activation J Biol Chem 273 1998 5801 5807
20. G.M. Greig, D.A. Francis, and J.P. Falgueyret The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs Mol Pharmacol 52 1997 829 838
21. D.L. DeWitt, E.A. Meade, and W.L. Smith PGH synthase isoenzyme selectivity: the potential for safer nonsteroidal antiinflammatory drugs Am J Med 95 1993 40S 44S
22. J.A. Mitchell, P. Akarasereenont, C. Thiemermann, R.J. Flower, and J.R. Vane Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase Proc Natl Acad Sci U S A 90 1993 11693 11697
23. C.J. Smith, Y. Zhang, and C.M. Koboldt Pharmacological analysis of cyclooxygenase-1 in inflammation Proc Natl Acad Sci U S A 95 1998 13313 13318
24. Y. Zhang, A. Shaffer, J. Portanova, K. Seibert, and P.C. Isakson Inhibition of cyclooxygenase-2 rapidly reverses inflammatory hyperalgesia and prostaglandin E2 production J Pharmacol Exp Ther 283 1997 1069 1075
25. D.M. Dirig, P.C. Isakson, and T.L. Yaksh Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats J Pharmacol Exp Ther 285 1998 1031 1038
26. B. Samuelsson, P. Borgeat, S. Hammarstrom, and R.C. Murphy Leukotrienes: a new group of biologically active compounds Adv Prostaglandin Thromboxane Res 6 1980 1 18
27. B. Samuelsson, S. Hammarstrom, R.C. Murphy, and P. Borgeat Leukotrienes and slow reacting substance of anaphylaxis (SRS-A) Allergy 35 1980 375 381
28. C.N. Serhan, and J. Savill Resolution of inflammation: the beginning programs the end Nat Immunol 6 2005 1191 1197
29. R.J. Flower, and G.J. Blackwell Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation Nature 278 1979 456 459
30. G.J. Blackwell, R. Carnuccio, M. Di Rosa, R.J. Flower, L. Parente, and P. Persico Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids Nature 287 1980 147 149
31. R. Carnuccio, M. Di Rosa, R.J. Flower, and A. Pinto The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leucocytes is correlated with intracellular macrocortin levels Br J Pharmacol 74 1981 322 324
32. G.J. Blackwell, R. Carnuccio, and M. Di Rosa Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat Br J Pharmacol 76 1982 185 194
33. M. Di Rosa, R.J. Flower, F. Hirata, L. Parente, and F. Russo-Marie Anti-phospholipase proteins Prostaglandins 28 1984 441 442
34. R.B. Pepinsky, L.K. Sinclair, and J.L. Browning Purification and partial sequence analysis of a 37-kDa protein that inhibits phospholipase A2 activity from rat peritoneal exudates J Biol Chem 261 1986 4239 4246
35. B.P. Wallner, R.J. Mattaliano, and C. Hession Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity Nature 320 1986 77 81
36. R.H. Kretsinger, and C.E. Creutz Cell biology. Consensus in exocytosis Nature 320 1986 573
37. S.E. Moss, and R.O. Morgan The annexins Genome Biol 5 2004 219
38. J.M. Iglesias, R.O. Morgan, N.A. Jenkins, N.G. Copeland, D.J. Gilbert, and M.P. Fernandez Comparative genetics and evolution of annexin A13 as the founder gene of vertebrate annexins Mol Biol Evol 19 2002 608 618
39. L. Liu, A.B. Fisher, and U.J. Zimmerman Regulation of annexin I by proteolysis in rat alveolar epithelial type II cells Biochem Mol Biol Int 36 1995 373 381
40. S.M. Oliani, M.J. Paul-Clark, H.C. Christian, R.J. Flower, and M. Perretti Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression Am J Pathol 158 2001 603 615
41. L. Vong, F. D'Acquisto, and M. Pederzoli-Ribeil Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3 J Biol Chem 282 2007 29998 30004
42. 2+ to annexin I J Mol Biol 306 2001 825 835
43. A. Rosengarth, V. Gerke, and H. Luecke X-ray structure of full-length annexin 1 and implications for membrane aggregation J Mol Biol 306 2001 489 498
44. R.A. Fava, J. McKanna, and S. Cohen Lipocortin I (p35) is abundant in a restricted number of differentiated cell types in adult organs J Cell Physiol 141 1989 284 293
45. V. Gerke, and S.E. Moss Annexins: from structure to function Physiol Rev 82 2002 331 371
46. J.D. Ernst, E. Hoye, R.A. Blackwood, and D. Jaye Purification and characterization of an abundant cytosolic protein from human neutrophils that promotes Ca2(+)-dependent aggregation of isolated specific granules J Clin Invest 85 1990 1065 1071
47. M. Perretti, H. Christian, and S.K. Wheller Annexin I is stored within gelatinase granules of human neutrophils and mobilised on the cell surface upon adhesion but not phagocytosis Cell Biol Int 24 2000 163 174
48. S.M. Oliani, H.C. Christian, J. Manston, R.J. Flower, and M. Perretti An immunocytochemical and in situ hybridization analysis of annexin 1 expression in rat mast cells: modulation by inflammation and dexamethasone Lab Invest 80 2000 1429 1438
49. S.H. Peers, F. Smillie, A.J. Elderfield, and R.J. Flower Glucocorticoid- and non-glucocorticoid induction of lipocortins (annexins) 1 and 2 in rat peritoneal leucocytes in vivo Br J Pharmacol 108 1993 66 72
50. J. Seemann, K. Weber, and V. Gerke Annexin I targets S100C to early endosomes FEBS Lett 413 1997 185 190
51. R. Bianchi, I. Giambanco, C. Arcuri, and R. Donato Subcellular localization of S100A11 (S100C) in LLC-PK1 renal cells: calcium- and protein kinase c-dependent association of S100A11 with S100B and vimentin intermediate filaments Microsc Res Tech 60 2003 639 651
52. C.E. Futter, S. Felder, J. Schlessinger, A. Ullrich, and C.R. Hopkins Annexin I is phosphorylated in the multivesicular body during the processing of the epidermal growth factor receptor J Cell Biol 120 1993 77 83
53. M. Perretti, J.D. Croxtall, S.K. Wheller, N.J. Goulding, R. Hannon, and R.J. Flower Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration Nat Med 2 1996 1259 1262
54. J.F. Morris, H.C. Christian, and L.P. Chapman Steroid effects on secretion from subsets of lactotrophs: role of folliculo-stellate cells and annexin 1 Arch Physiol Biochem 110 2002 54 61
55. L.P. Chapman, M.J. Epton, J.C. Buckingham, J.F. Morris, and H.C. Christian Evidence for a role of the adenosine 5′-triphosphate-binding cassette transporter A1 in the externalization of annexin I from pituitary folliculo-stellate cells Endocrinology 144 2003 1062 1073
56. J.D. Croxtall, Q. Choudhury, and R.J. Flower Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent, transcription-independent mechanism Br J Pharmacol 130 2000 289 298
57. C.D. John, H.C. Christian, J.F. Morris, R.J. Flower, E. Solito, and J.C. Buckingham Kinase-dependent regulation of the secretion of thyrotrophin and luteinizing hormone by glucocorticoids and annexin 1 peptides J Neuroendocrinol 15 2003 946 957
58. E. Solito, A. Mulla, J.F. Morris, H.C. Christian, R.J. Flower, and J.C. Buckingham Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase Endocrinology 144 2003 1164 1174
59. A. Mulla, C. Leroux, E. Solito, and J.C. Buckingham Correlation between the antiinflammatory protein annexin 1 (lipocortin 1) and serum cortisol in subjects with normal and dysregulated adrenal function J Clin Endocrinol Metab 90 2005 557 562
60. F. D'Acquisto, M. Perretti, and R.J. Flower Annexin-A1: a pivotal regulator of the innate and adaptive immune systems Br J Pharmacol 155 2008 152 169
61. J.D. Croxtall, Q. Choudhury, S. Newman, and R.J. Flower Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation Biochem Pharmacol 52 1996 351 356
62. J.L. Masferrer, K. Seibert, B. Zweifel, and P. Needleman Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme Proc Natl Acad Sci U S A 89 1992 3917 3921
63. A. Walther, K. Riehemann, and V. Gerke A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR Mol Cell 5 2000 831 840
64. M.A. Panaro, A. Acquafredda, M. Sisto, S. Lisi, A.B. Maffione, and V. Mitolo Biological role of the N-formyl peptide receptors Immunopharmacol Immunotoxicol 28 2006 103 127
65. M. Perretti, N. Chiang, and M. La Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor Nat Med 8 2002 1296 1302
66. F.N. Gavins, S. Yona, A.M. Kamal, R.J. Flower, and M. Perretti Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms Blood 101 2003 4140 4147
67. S. Fiore, S.W. Ryeom, P.F. Weller, and C.N. Serhan Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils J Biol Chem 267 1992 16168 16176
68. J.F. Maddox, M. Hachicha, T. Takano, N.A. Petasis, V.V. Fokin, and C.N. Serhan Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor J Biol Chem 272 1997 6972 6978
69. S. Krishnamoorthy, A. Recchiuti, and N. Chiang Resolvin D1 binds human phagocytes with evidence for proresolving receptors Proc Natl Acad Sci U S A 107 2010 1660 1665
70. N. Dufton, R. Hannon, and V. Brancaleone Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation J Immunol 184 2010 2611 2619
71. N. Chiang, C.N. Serhan, and S.E. Dahlen The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo Pharmacol Rev 58 2006 463 487
72. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat Immunol 2 2001 612 619
73. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution Prostaglandins Leukot Essent Fatty Acids 73 2005 141 162
74. C.N. Serhan, and N.A. Petasis Resolvins and protectins in inflammation resolution Chem Rev 111 10 2011 5922 5943
75. T. Morris, M. Stables, and P. Colville-Nash Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways Proc Natl Acad Sci U S A 107 2010 8842 8847
76. N. Chiang, I.M. Fierro, K. Gronert, and C.N. Serhan Activation of lipoxin A(4) receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation J Exp Med 191 2000 1197 1208
77. M. Arita, F. Bianchini, and J. Aliberti Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J Exp Med 201 2005 713 722
78. M. Arita, S.F. Oh, and T. Chonan Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions J Biol Chem 281 2006 22847 22854
79. J.-L. Gao, H. Chen, J.D. Filie, C.A. Kozak, and P.M. Murphy Differential expansion of the N-formylpeptide receptor gene cluster in human and mouse Genomics 51 1998 270 276
80. R.D. Ye, F. Boulay, and J.M. Wang International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family Pharmacol Rev 61 2009 119 161
81. -/- mouse FASEB J 17 2003 253 255
82. V. Brancaleone, J. Dalli, S. Bena, R.J. Flower, G. Cirino, and M. Perretti Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature J Immunol 186 8 2011 4905 4914
83. K. Chen, Y. Le, and Y. Liu A critical role for the g protein-coupled receptor mFPR2 in airway inflammation and immune responses J Immunol 184 2010 3331 3335
84. K. De Bosscher, W. Vanden Berghe, and G. Haegeman Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors J Neuroimmunol 109 2000 16 22
85. J.S. Cox Disodium cromoglycate (FPL 670) ('Intal'): a specific inhibitor of reaginic antibody-antigen mechanisms Nature 216 1967 1328 1329
86. H. Cairns, D. Cox, K.J. Gould, A.H. Ingall, and J.L. Suschitzky New antiallergic pyrano [3,2-g]quinoline-2,8-dicarboxylic acids with potential for the topical treatment of asthma J Med Chem 28 1985 1832 1842
87. E.B. Cook, J.L. Stahl, N.P. Barney, and F.M. Graziano Mechanisms of antihistamines and mast cell stabilizers in ocular allergic inflammation Curr Drug Targets Inflamm Allergy 1 2002 167 180
88. J.S. Cox, and R.E. Altounyan Nature and modes of action of disodium cromoglycate (Lomudal) Respiration 27 Suppl. 1970 292 309
89. A.B. Kay, G.M. Walsh, and R. Moqbel Disodium cromoglycate inhibits activation of human inflammatory cells in vitro J Allergy Clin Immunol 80 1987 1 8
90. S. Mattoli, M. Mezzetti, A. Fasoli, F. Patalano, and L. Allegra Nedocromil sodium prevents the release of 15-hydroxyeicosatetraenoic acid from human bronchial epithelial cells exposed to toluene diisocyanate in vitro Int Arch Allergy Appl Immunol 92 1990 16 22
91. C. Rusznak, J.L. Devalia, R.J. Sapsford, and R.J. Davies Ozone-induced mediator release from human bronchial epithelial cells in vitro and the influence of nedocromil sodium Eur Respir J 9 1996 2298 2305
92. P.J. Barnes Anti-inflammatory therapy for asthma Annu Rev Med 44 1993 229 242
93. D.S. Thomson, and D.P. Evans Inhibition of immediate hypersensitivity reactions by disodium cromoglycate Clin Exp Immunol 13 1973 537 544
94. T.C. Theoharides, L. Wang, and X. Pang Cloning and cellular localization of the rat mast cell 78-kDa protein phosphorylated in response to the mast cell stabilizer cromolyn J Pharmacol Exp Ther 294 2000 810 821
95. R. Sagi-Eisenberg Possible role for a calcium-activated phospholipid-dependent protein kinase in mode of action of DSCG Trends Pharmacol Sci 6 1985 198 200
96. E. Solito, G. Raugei, M. Melli, and L. Parente Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells FEBS Lett 291 1991 238 244
97. S. Yazid, E. Solito, H. Christian, S. McArthur, N. Goulding, and R. Flower Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1 Biochem Pharmacol 77 2009 1814 1826
98. S. Yazid, G. Leoni, and S.J. Getting Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization Arterioscler Thromb Vasc Biol 30 2010 1718 1724